{"gene":"ATP1A3","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2004,"finding":"Six missense mutations in ATP1A3 (encoding the Na+/K+-ATPase α3 subunit) were identified in rapid-onset dystonia-parkinsonism (RDP/DYT12) families; functional studies and structural analysis indicated these mutations impair enzyme activity or stability of the Na+/K+ pump.","method":"Missense mutation identification, functional studies, structural analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — functional enzymatic assays combined with structural analysis, replicated across multiple families and subsequently confirmed by many independent labs","pmids":["15260953"],"is_preprint":false},{"year":2012,"finding":"De novo nonsynonymous ATP1A3 mutations in alternating hemiplegia of childhood (AHC) cause consistent reductions in ATPase activity without affecting protein expression level, distinguishing them mechanistically from RDP mutations which impair enzyme activity or stability.","method":"Exome sequencing, ATPase activity assays in patient-derived cells, protein expression analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct in vitro enzymatic assay with multiple mutations, replicated across large cohort, multiple orthogonal methods","pmids":["22842232"],"is_preprint":false},{"year":2009,"finding":"An in-frame C-terminal insertion mutation in ATP1A3 causes RDP by drastically reducing Na+ affinity at the third Na+ binding site, without defects in protein biogenesis or plasma membrane targeting; structural modelling demonstrated the C-terminus interacts with the third Na+ binding site to stabilize E1/E2 conformations.","method":"Expression studies, functional Na+ affinity analysis, structural modelling, ouabain challenge survival assay","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic characterization with mutagenesis and structural modelling, single lab but multiple orthogonal methods","pmids":["19351654"],"is_preprint":false},{"year":2015,"finding":"Novel ATP1A3 mutations (p.Gly358Val and p.Ile363Asn) localizing to the P domain result in significant reduction of Na,K-ATPase activity in vitro; ATP1A3 immunofluorescence in human brain tissue is prominently associated with interneurons in the cortex.","method":"In vitro ATPase activity assay, immunofluorescence in human brain tissue","journal":"Epilepsia","confidence":"Medium","confidence_rationale":"Tier 1-2 / Weak — direct in vitro enzymatic assay, single lab study","pmids":["25656163"],"is_preprint":false},{"year":2013,"finding":"In Atp1a3 heterozygous knockout mice, the α3 subunit is concentrated presynaptically at Purkinje cell soma (co-localizing with VGAT), and loss of one Atp1a3 allele enhances inhibitory neurotransmission at molecular-layer interneuron–Purkinje cell synapses via a presynaptic mechanism, leading to increased dystonia symptoms after cerebellar kainate injection.","method":"Immunohistochemistry, electrophysiology (patch-clamp of cerebellar slices), Atp1a3 heterozygous knockout mouse, behavioral dystonia assay","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal localization and electrophysiology in KO mouse with defined cellular phenotype, multiple orthogonal methods in single study","pmids":["23652595"],"is_preprint":false},{"year":2019,"finding":"ATP1A3 mutations causing severe phenotypes (microcephaly, brain atrophy) produce protein misfolding during biosynthesis, resulting in impaired trafficking of the α3β complex from ER through Golgi to plasma membrane; additionally, exogenous mutant α3 competes with endogenous α1 such that their total is constant, predicting variable ratios of normal to mutant protein in patients.","method":"Tetracycline-inducible isogenic HEK-293 cell lines, subcellular fractionation, immunofluorescence for Golgi/ER markers, Western blotting, cell survival assays","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal cell-biological methods in isogenic lines, single lab","pmids":["31425744"],"is_preprint":false},{"year":2020,"finding":"Severe ATP1A3 mutations (e.g., L924P) cause greater ER retention of nascent α3, more ER-associated degradation (ERAD), larger perturbation of Na,K-ATPase subunit subcellular distribution, greater eIF2α inactivation (unfolded protein response), altered distribution of endogenous α1 (dominant-negative-like effect), and pro-apoptotic sensitization via reduced BAD phosphorylation; the pharmacological corrector 4-phenylbutyrate reduces L924P ER retention and restores morphology.","method":"Isogenic inducible cell lines, subcellular fractionation, Western blotting, UPR pathway analysis, pharmacological rescue with 4-PBA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal mechanistic assays in isogenic cell system, pharmacological validation, single lab","pmids":["33144327"],"is_preprint":false},{"year":2018,"finding":"The CAPOS mutation p.Glu818Lys in ATP1A3 specifically affects sodium binding to and release from the third (sodium-specific) ion-binding site of the pump, as demonstrated by in vitro electrophysiological studies; molecular dynamics simulations confirm structural perturbation of the C-terminal region.","method":"Heterologous expression, in vitro electrophysiology (pump current measurements), molecular dynamics simulation","journal":"Human genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct electrophysiological measurement of ion binding kinetics plus molecular dynamics, multiple orthogonal methods, single lab","pmids":["29305691"],"is_preprint":false},{"year":2021,"finding":"ATP1A3 is expressed in fetal cortical subplate excitatory neurons and postnatal inhibitory neurons (including parvalbumin interneurons); the Na+/K+-ATPase pump complex forms cell-type-specific α-β isoform combinations: α3-β1 in excitatory neurons and α3-β2 in inhibitory neurons, as shown by single-cell RNA sequencing of ~125,000 fetal cortical cells.","method":"mRNA in situ hybridization, single-cell RNA sequencing (Drop-seq) of ~125,000 fetal cortical cells and ~52,000 infant cortical nuclei","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — large-scale single-cell transcriptomics with in situ validation, cell-type specific isoform pairing established, single lab but large dataset with orthogonal validation","pmids":["34161264"],"is_preprint":false},{"year":2022,"finding":"The p.Arg756His mutation in ATP1A3 reduces protein turnover rate and Na+ affinity and increases K+ affinity; at 39°C (fever), α3 protein level drops due to internalization from the cell surface and lysosomal/endosomal routing, without loss of β subunit; recovery requires new protein synthesis; heating in vitro causes activity loss 20-30-fold faster than wildtype, demonstrating temperature-dependent structural destabilization. Arg756 normally forms hydrogen bonds anchoring four linearly distant structural regions.","method":"Isogenic mammalian cell lines, transport activity assays at 37°C and 39°C, immunofluorescence for subcellular localization (LAMP1 marker), cycloheximide chase, in vitro heating activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal assays (activity, localization, thermal stability, biosynthesis) in controlled isogenic cells, single lab","pmids":["36462665"],"is_preprint":false},{"year":2020,"finding":"Twelve RDP and AHC-specific ATP1A3 mutations expressed in HEK cells and Xenopus oocytes all showed functional impairment (lower cell survival and reduced pump current), but no difference in extent of impairment or expression level was found between RDP and AHC phenotypes, indicating that pump dysfunction magnitude alone does not determine disease severity.","method":"Transfected HEK cells, Xenopus oocyte electrophysiology (pump current measurement), cell survival assay","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct electrophysiological and enzymatic assays across 12 mutations, multiple expression systems, single lab","pmids":["32653672"],"is_preprint":false},{"year":2017,"finding":"Complete knockout of Atp1a3 (Atp1a3-/-) in mice results in perinatal seizures, failure of effective breathing, and death; knockout brains show elevated c-Fos expression in multiple regions (with unique cerebellar distribution) and higher dopamine and noradrenaline contents; brainstem preparations show abnormal respiratory rhythms, demonstrating α3 is required for normal respiratory rhythm generation and monoamine homeostasis.","method":"Atp1a3 knockout mouse, c-Fos immunohistochemistry, monoamine HPLC measurement, brainstem preparation electrophysiology, behavioral observation","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO mouse with multiple defined cellular/physiological phenotypes using orthogonal methods, single lab","pmids":["28465228"],"is_preprint":false},{"year":2023,"finding":"The recurrent ATP1A3 p.Pro775Leu variant uniquely causes leakage of sodium ions and protons into the cell (cation leak), associated with impaired sodium binding/occlusion kinetics favouring states with fewer bound ions, producing a mild spasticity/intellectual disability phenotype distinct from other ATP1A3-related syndromes.","method":"Electrophysiological characterization of ion transport kinetics in heterologous expression system, biophysical analysis of sodium occlusion","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct electrophysiological assay revealing novel cation leak mechanism, single lab, novel mechanism with functional validation","pmids":["37043503"],"is_preprint":false},{"year":2024,"finding":"The intracellular loop (ICL) of ATP1A3 interacts with RNA-binding proteins Eif4g (Eif4g1), Pabpc1, and Fmrp (Fmr1) in mouse Neuro2a cells; siRNA depletion of Atp1a3 or expression of p.R756C ATP1A3-ICL causes excessive phosphorylation of ribosomal protein S6 and increased susceptibility to heat stress; patient iPSC-derived neurons with p.R756C showed reduced calcium influx in response to ATP stimulation.","method":"Co-immunoprecipitation/pulldown for RNA-binding protein interaction, siRNA knockdown, ectopic expression of ICL domain, S6 phosphorylation Western blotting, heat stress assay, iPSC-derived neurons, calcium imaging","journal":"Disease models & mechanisms","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — protein-protein interaction and downstream signalling with multiple orthogonal methods, single lab, novel ICL binding partner finding","pmids":["38804677"],"is_preprint":false},{"year":2025,"finding":"In Atp1a3 mutant mice (D801N), motor neurons exhibit loss of Na+/K+-ATPase-mediated afterhyperpolarization and impaired intracellular sodium extrusion, resulting in reduced responsiveness of the spinal motor network to activity-dependent sodium rises and a hyperexcitable motor phenotype compatible with dystonia.","method":"Atp1a3 mutant mouse (D801N knock-in), intracellular electrophysiology of motor neurons, sodium imaging, spinal motor network recordings","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct electrophysiological measurement of afterhyperpolarization and sodium homeostasis in knock-in mouse, multiple orthogonal methods, single lab","pmids":["39533828"],"is_preprint":false},{"year":2021,"finding":"AAV9-mediated delivery of human ATP1A3 under the Synapsin promoter into Atp1a3 D801N mutant mice increased ouabain-sensitive ATPase activity in brain regions, reduced inducible hemiplegia spells, improved balance beam performance, and prolonged survival, demonstrating that supplementing wild-type α3 pump activity can rescue disease phenotypes.","method":"AAV9 gene delivery (intracerebroventricular and intracisterna magna injection), ATPase activity assay, behavioral testing, survival analysis in knock-in mice","journal":"Human gene therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo functional rescue with enzymatic validation and behavioral readouts, single lab","pmids":["33577387"],"is_preprint":false},{"year":2013,"finding":"Platelets and fibroblasts from AHC patients with ATP1A3 mutations (D801N or E815K) show lysosomal granule structural and functional abnormalities (CD63+ granule defects) and significantly increased activated cathepsin B levels, leading to enhanced intrinsic apoptosis.","method":"Platelet and fibroblast morphology, flow cytometry (CD63), proteomic analysis (TMT), cathepsin B activity assay, apoptosis assay","journal":"Journal of proteomics","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — multiple orthogonal methods in patient-derived cells across two cell types, single lab","pmids":["23681173"],"is_preprint":false},{"year":2025,"finding":"In iPSC-derived cardiomyocytes from D801N ATP1A3 patients, the D801N variant shortens action potential duration, increases mean diastolic potential, and causes delayed afterdepolarizations compared to controls, consistent with short QT interval and arrhythmic susceptibility observed clinically; the D801N variant and other short-QT-associated variants localize to the potassium-binding domain of ATP1A3.","method":"iPSC-derived cardiomyocytes, action potential recordings, cryo-EM structure mapping, clinical QTc measurements","journal":"JAMA pediatrics","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct electrophysiological validation in patient-derived iPSC-cardiomyocytes combined with structural domain mapping and clinical data, multiple orthogonal methods","pmids":["40029639"],"is_preprint":false},{"year":2016,"finding":"The ATP1A3 G316S mutation modelled in C. elegans eat-6 (orthologue of ATP1A3) via CRISPR/Cas9 knock-in causes dominant loss-of-function at the neuromuscular junction: decreased pharyngeal pumping rate and hypersensitivity to aldicarb (acetylcholinesterase inhibitor), demonstrating impaired neuromuscular function.","method":"CRISPR/Cas9 knock-in in C. elegans, pharyngeal pumping assay, aldicarb sensitivity assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo CRISPR knock-in model with two behavioural assays establishing dominant loss-of-function mechanism at NMJ, single lab","pmids":["27936181"],"is_preprint":false},{"year":2013,"finding":"The porcine ATP1A3 promoter drives expression specifically in embryonic brain and spinal cord neurons in transgenic zebrafish, confirming neuron-specific transcriptional activity; ATP1A3 mRNA expression is confined to neuronal tissue with expression detectable in embryonic porcine brain from 60 days of gestation.","method":"Transgenic zebrafish reporter assay, qRT-PCR tissue expression profiling, protein immunoblotting","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic promoter assay with qPCR and protein validation, single lab, multiple orthogonal methods","pmids":["24236096"],"is_preprint":false}],"current_model":"ATP1A3 encodes the neuron-specific α3 catalytic subunit of the Na+/K+-ATPase pump, which maintains electrochemical gradients essential for neuronal excitability; pathogenic mutations impair pump ATPase activity, reduce Na+ affinity, cause protein misfolding/ER retention with activation of the unfolded protein response, disrupt α3β isoform trafficking to the plasma membrane, abolish the Na+/K+-ATPase-mediated afterhyperpolarization in motor neurons (resulting in hyperexcitability and dystonia), and in some cases cause cation leak or temperature-dependent structural destabilization; the α3 subunit also interacts with RNA-binding proteins via its intracellular loop to regulate protein synthesis under stress, forms cell-type-specific heteromeric complexes (α3-β1 in excitatory, α3-β2 in inhibitory neurons), and its dysfunction in cardiac cells impairs ventricular repolarization causing arrhythmic susceptibility."},"narrative":{"mechanistic_narrative":"ATP1A3 encodes the neuron-specific α3 catalytic subunit of the Na+/K+-ATPase, the active ion pump whose ouabain-sensitive ATPase activity maintains transmembrane Na+/K+ gradients required for neuronal excitability, and its expression is restricted to neuronal tissue of the brain and spinal cord [PMID:28465228, PMID:24236096]. The pump assembles into cell-type-specific heteromeric complexes, pairing α3 with β1 in excitatory neurons and with β2 in inhibitory interneurons [PMID:34161264]. Heterozygous and missense loss-of-function alleles cause a spectrum of dominant neurological disease — rapid-onset dystonia-parkinsonism (RDP/DYT12), alternating hemiplegia of childhood (AHC), and CAPOS — through several distinct biophysical lesions: reduction of catalytic ATPase activity [PMID:15260953, PMID:22842232, PMID:25656163, PMID:32653672], loss of Na+ affinity at the third (sodium-specific) ion-binding site via C-terminal perturbation [PMID:19351654, PMID:29305691], pathological cation leak of Na+ and protons [PMID:37043503], and temperature-dependent structural destabilization that triggers fever-induced surface loss of α3 [PMID:36462665]. The most severe alleles act through a biogenesis defect: misfolded nascent α3 is retained in the ER, undergoes ERAD, activates the unfolded protein response via eIF2α, exerts a dominant-negative effect on endogenous α1 distribution, and sensitizes cells to apoptosis, a phenotype reversible by the chemical chaperone 4-phenylbutyrate [PMID:31425744, PMID:33144327]. At the circuit level α3 dysfunction abolishes Na+/K+-ATPase-mediated afterhyperpolarization in motor neurons and dysregulates inhibitory transmission, producing hyperexcitability and dystonia [PMID:23652595, PMID:39533828], while complete loss is incompatible with normal respiratory rhythm and monoamine homeostasis [PMID:28465228]. Beyond ion transport, the α3 intracellular loop binds the RNA-binding proteins Eif4g1, Pabpc1, and Fmrp to restrain ribosomal S6 phosphorylation and protein synthesis under stress [PMID:38804677]. α3 dysfunction also impairs cardiac repolarization, causing short-QT and arrhythmic susceptibility [PMID:40029639]. Restoring wild-type α3 pump activity by AAV9 gene delivery rescues disease phenotypes in mutant mice, establishing reduced pump function as the proximate cause [PMID:33577387].","teleology":[{"year":2004,"claim":"Established ATP1A3 as a disease gene by linking missense mutations to rapid-onset dystonia-parkinsonism and tying them to impaired pump enzyme activity/stability.","evidence":"Mutation identification in RDP families with functional and structural analysis","pmids":["15260953"],"confidence":"High","gaps":["Did not resolve which biophysical step of the pump cycle each mutation impairs","No in vivo circuit-level mechanism"]},{"year":2009,"claim":"Resolved one biophysical lesion: a C-terminal insertion reduces Na+ affinity at the third Na+ site without affecting biogenesis or membrane targeting, implicating the C-terminus in stabilizing E1/E2 conformations.","evidence":"Heterologous expression, Na+ affinity assays, structural modelling, ouabain survival assay","pmids":["19351654"],"confidence":"High","gaps":["Generalizability to other RDP mutations unaddressed","No direct structure of mutant pump"]},{"year":2012,"claim":"Distinguished AHC from RDP mechanistically by showing AHC de novo mutations reduce ATPase activity without altering protein expression level.","evidence":"Exome sequencing plus ATPase activity and expression assays in patient cells","pmids":["22842232"],"confidence":"High","gaps":["Did not explain phenotypic divergence given shared activity loss","No structural mapping of severity"]},{"year":2013,"claim":"Defined the cellular and synaptic consequences of α3 loss in vivo, localizing the subunit presynaptically and linking haploinsufficiency to enhanced inhibition and dystonia.","evidence":"Atp1a3 heterozygous KO mouse, immunohistochemistry, cerebellar slice electrophysiology, behavioral dystonia assay","pmids":["23652595"],"confidence":"High","gaps":["Presynaptic mechanism for enhanced inhibition not fully resolved","Cerebellar focus leaves other circuits open"]},{"year":2013,"claim":"Extended pathology beyond ion transport, showing patient cells carry lysosomal granule defects and elevated cathepsin B driving apoptosis.","evidence":"Patient platelet/fibroblast morphology, CD63 flow cytometry, proteomics, cathepsin B and apoptosis assays","pmids":["23681173"],"confidence":"Medium","gaps":["Causal link from pump dysfunction to lysosomal phenotype not established","Two cell types, single lab"]},{"year":2017,"claim":"Demonstrated α3 is essential for life by showing complete knockout causes perinatal lethality, respiratory rhythm failure, and monoamine dysregulation.","evidence":"Atp1a3 knockout mouse, c-Fos IHC, monoamine HPLC, brainstem electrophysiology","pmids":["28465228"],"confidence":"High","gaps":["Cell-autonomous vs network origin of respiratory failure unresolved","Monoamine changes mechanism unclear"]},{"year":2018,"claim":"Provided direct biophysical evidence that the CAPOS mutation specifically disrupts Na+ binding/release at the third ion site through C-terminal perturbation.","evidence":"Heterologous expression, pump current electrophysiology, molecular dynamics simulation","pmids":["29305691"],"confidence":"High","gaps":["Link from biophysical defect to CAPOS-specific clinical features not established"]},{"year":2019,"claim":"Identified protein misfolding and trafficking failure as the lesion behind the most severe phenotypes, with mutant α3 competing with α1 to set a fixed total subunit pool.","evidence":"Isogenic inducible HEK-293 lines, fractionation, ER/Golgi immunofluorescence, Western blot","pmids":["31425744"],"confidence":"Medium","gaps":["In vivo relevance of competition model untested","Single cell system"]},{"year":2020,"claim":"Detailed the biogenesis defect mechanistically (ER retention, ERAD, UPR via eIF2α, dominant-negative effect on α1, apoptotic sensitization) and showed pharmacological correction by 4-PBA.","evidence":"Isogenic inducible cell lines, fractionation, UPR pathway analysis, 4-PBA rescue","pmids":["33144327"],"confidence":"High","gaps":["Whether 4-PBA rescues function in neurons untested","Single lab cell model"]},{"year":2020,"claim":"Tested whether magnitude of pump dysfunction explains phenotype severity and found it does not, decoupling activity loss from RDP-vs-AHC outcome.","evidence":"12 mutations in HEK cells and Xenopus oocytes, pump current and survival assays","pmids":["32653672"],"confidence":"High","gaps":["What does determine severity remains unidentified","In vitro systems lack neuronal context"]},{"year":2021,"claim":"Mapped cell-type-specific subunit pairing, showing α3-β1 in excitatory and α3-β2 in inhibitory neurons and developmental shifts in expression.","evidence":"Single-cell RNA-seq of ~125,000 fetal cortical cells with in situ hybridization validation","pmids":["34161264"],"confidence":"High","gaps":["Functional consequence of isoform pairing untested","Transcript-level pairing not validated at protein-complex level"]},{"year":2021,"claim":"Established that supplementing wild-type α3 pump activity is therapeutic, providing causal proof that pump deficiency drives disease.","evidence":"AAV9-Synapsin ATP1A3 delivery in D801N mice, ATPase assay, behavior, survival","pmids":["33577387"],"confidence":"Medium","gaps":["Durability and translatability untested","Did not address dominant-negative alleles"]},{"year":2022,"claim":"Explained fever-triggered episodes by showing a mutation confers temperature-dependent destabilization with surface internalization and lysosomal routing at 39°C.","evidence":"Isogenic cells, transport assays at 37/39°C, LAMP1 immunofluorescence, cycloheximide chase, in vitro thermal stability","pmids":["36462665"],"confidence":"High","gaps":["In vivo confirmation in neurons during fever lacking","Trafficking machinery mediating internalization unidentified"]},{"year":2023,"claim":"Identified cation leak as a distinct disease mechanism, with a variant allowing Na+ and proton leak associated with a milder phenotype.","evidence":"Electrophysiological ion transport kinetics and occlusion analysis in heterologous expression","pmids":["37043503"],"confidence":"High","gaps":["Cellular consequences of leak in neurons untested","Single lab"]},{"year":2024,"claim":"Revealed a non-pumping moonlighting function: the α3 intracellular loop binds RNA-binding proteins to regulate translation and stress responses.","evidence":"Co-IP for Eif4g1/Pabpc1/Fmr1, siRNA, ICL ectopic expression, S6 phosphorylation, heat stress, iPSC neuron calcium imaging","pmids":["38804677"],"confidence":"Medium","gaps":["Direct vs indirect binding not resolved by single Co-IP-based study","Physiological relevance of translation control in vivo untested"]},{"year":2025,"claim":"Connected α3 dysfunction to a circuit-level dystonia mechanism: loss of pump-mediated afterhyperpolarization and impaired Na+ extrusion produce motor neuron hyperexcitability.","evidence":"D801N knock-in mouse, motor neuron intracellular electrophysiology, sodium imaging, spinal network recordings","pmids":["39533828"],"confidence":"High","gaps":["Translation to human motor circuits untested","Therapeutic correction at this level not shown"]},{"year":2025,"claim":"Extended α3 function to cardiac repolarization, showing the D801N variant shortens action potentials and causes afterdepolarizations underlying short-QT arrhythmia risk.","evidence":"Patient iPSC-derived cardiomyocytes, action potential recordings, cryo-EM domain mapping, clinical QTc","pmids":["40029639"],"confidence":"High","gaps":["Mechanism linking K+-binding-domain variants to repolarization not fully resolved","In vivo arrhythmia modeling lacking"]},{"year":null,"claim":"What determines the divergent clinical phenotypes (RDP, AHC, CAPOS, spasticity, short-QT) given that activity-loss magnitude alone does not predict severity remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying genotype-phenotype mechanistic model","Relative contribution of pump-loss, cation leak, misfolding, and moonlighting functions to specific syndromes unquantified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,1,10,15]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[2,7,12]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1,3]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[4,14]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,9]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5,6]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[5]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[9,16]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[2,7,12]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[4,14,11]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[6,9]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,1]}],"complexes":["Na+/K+-ATPase (α3-β1 / α3-β2 heteromer)"],"partners":["ATP1B1","ATP1B2","ATP1A1","EIF4G1","PABPC1","FMR1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P13637","full_name":"Sodium/potassium-transporting ATPase subunit alpha-3","aliases":["Na(+)/K(+) ATPase alpha(III) subunit","Sodium pump subunit alpha-3"],"length_aa":1013,"mass_kda":111.7,"function":"This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P13637/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP1A3","classification":"Not Classified","n_dependent_lines":19,"n_total_lines":1208,"dependency_fraction":0.015728476821192054},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ATP1A3","total_profiled":1310},"omim":[{"mim_id":"619606","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99; DEE99","url":"https://www.omim.org/entry/619606"},{"mim_id":"619605","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98; DEE98","url":"https://www.omim.org/entry/619605"},{"mim_id":"615755","title":"FORKHEAD BOX R1; FOXR1","url":"https://www.omim.org/entry/615755"},{"mim_id":"614820","title":"ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2","url":"https://www.omim.org/entry/614820"},{"mim_id":"607321","title":"ATPase, Na+/K+ TRANSPORTING, ALPHA-4 POLYPEPTIDE; ATP1A4","url":"https://www.omim.org/entry/607321"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":279.0},{"tissue":"heart muscle","ntpm":147.7},{"tissue":"retina","ntpm":271.7}],"url":"https://www.proteinatlas.org/search/ATP1A3"},"hgnc":{"alias_symbol":[],"prev_symbol":["DYT12"]},"alphafold":{"accession":"P13637","domains":[{"cath_id":"2.70.150.10","chopping":"32-66_156-262","consensus_level":"high","plddt":88.898,"start":32,"end":262},{"cath_id":"-","chopping":"71-154","consensus_level":"medium","plddt":79.1108,"start":71,"end":154},{"cath_id":"1.20.1110.10","chopping":"300-325_757-982","consensus_level":"high","plddt":93.2495,"start":300,"end":982},{"cath_id":"3.40.50.1000","chopping":"346-365_586-743","consensus_level":"high","plddt":90.9702,"start":346,"end":743},{"cath_id":"3.40.1110.10","chopping":"376-581","consensus_level":"high","plddt":90.5736,"start":376,"end":581}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P13637","model_url":"https://alphafold.ebi.ac.uk/files/AF-P13637-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P13637-F1-predicted_aligned_error_v6.png","plddt_mean":88.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP1A3","jax_strain_url":"https://www.jax.org/strain/search?query=ATP1A3"},"sequence":{"accession":"P13637","fasta_url":"https://rest.uniprot.org/uniprotkb/P13637.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P13637/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P13637"}},"corpus_meta":[{"pmid":"15260953","id":"PMC_15260953","title":"Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism.","date":"2004","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/15260953","citation_count":365,"is_preprint":false},{"pmid":"22842232","id":"PMC_22842232","title":"De novo mutations in ATP1A3 cause alternating hemiplegia of childhood.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22842232","citation_count":333,"is_preprint":false},{"pmid":"22850527","id":"PMC_22850527","title":"Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study.","date":"2012","source":"The Lancet. Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22850527","citation_count":204,"is_preprint":false},{"pmid":"24739246","id":"PMC_24739246","title":"Distinct neurological disorders with ATP1A3 mutations.","date":"2014","source":"The Lancet. Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24739246","citation_count":200,"is_preprint":false},{"pmid":"17282997","id":"PMC_17282997","title":"The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene.","date":"2007","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17282997","citation_count":180,"is_preprint":false},{"pmid":"24468074","id":"PMC_24468074","title":"A novel recurrent mutation in ATP1A3 causes CAPOS syndrome.","date":"2014","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24468074","citation_count":151,"is_preprint":false},{"pmid":"26410222","id":"PMC_26410222","title":"Clinical profile of patients with ATP1A3 mutations in Alternating Hemiplegia of Childhood-a study of 155 patients.","date":"2015","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/26410222","citation_count":126,"is_preprint":false},{"pmid":"25447930","id":"PMC_25447930","title":"The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, Alternating Hemiplegia of Childhood, Rapid-onset Dystonia-Parkinsonism, CAPOS and beyond.","date":"2014","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25447930","citation_count":105,"is_preprint":false},{"pmid":"25656163","id":"PMC_25656163","title":"Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly.","date":"2015","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/25656163","citation_count":105,"is_preprint":false},{"pmid":"24523486","id":"PMC_24523486","title":"The expanding clinical and genetic spectrum of ATP1A3-related disorders.","date":"2014","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24523486","citation_count":95,"is_preprint":false},{"pmid":"26400718","id":"PMC_26400718","title":"Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation.","date":"2015","source":"Developmental medicine and child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26400718","citation_count":79,"is_preprint":false},{"pmid":"23409136","id":"PMC_23409136","title":"Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23409136","citation_count":77,"is_preprint":false},{"pmid":"22924536","id":"PMC_22924536","title":"ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia.","date":"2012","source":"Developmental medicine and child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22924536","citation_count":72,"is_preprint":false},{"pmid":"20850480","id":"PMC_20850480","title":"Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism.","date":"2010","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/20850480","citation_count":70,"is_preprint":false},{"pmid":"21418141","id":"PMC_21418141","title":"Decreased neuronal Na+, K+ -ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress.","date":"2011","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/21418141","citation_count":68,"is_preprint":false},{"pmid":"9646882","id":"PMC_9646882","title":"Evidence for an allelic association between bipolar disorder and a Na+, K+ adenosine triphosphatase alpha subunit gene (ATP1A3).","date":"1998","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9646882","citation_count":67,"is_preprint":false},{"pmid":"23652595","id":"PMC_23652595","title":"Enhanced inhibitory neurotransmission in the cerebellar cortex of Atp1a3-deficient heterozygous mice.","date":"2013","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23652595","citation_count":59,"is_preprint":false},{"pmid":"33341053","id":"PMC_33341053","title":"TMT-based quantitative proteomics reveals suppression of SLC3A2 and ATP1A3 expression contributes to the inhibitory role of acupuncture on airway inflammation in an OVA-induced mouse asthma model.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/33341053","citation_count":58,"is_preprint":false},{"pmid":"24842602","id":"PMC_24842602","title":"ATP1A3 mutations and genotype-phenotype correlation of alternating hemiplegia of childhood in Chinese patients.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24842602","citation_count":57,"is_preprint":false},{"pmid":"36192182","id":"PMC_36192182","title":"The Phenotypic Continuum of ATP1A3-Related Disorders.","date":"2022","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36192182","citation_count":55,"is_preprint":false},{"pmid":"28647130","id":"PMC_28647130","title":"Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 Mutation.","date":"2017","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28647130","citation_count":54,"is_preprint":false},{"pmid":"19351654","id":"PMC_19351654","title":"A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19351654","citation_count":52,"is_preprint":false},{"pmid":"33880529","id":"PMC_33880529","title":"ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.","date":"2021","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33880529","citation_count":50,"is_preprint":false},{"pmid":"29291920","id":"PMC_29291920","title":"ATP1A3-related disorders: An update.","date":"2017","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/29291920","citation_count":49,"is_preprint":false},{"pmid":"29184165","id":"PMC_29184165","title":"ATP1A3 mutations can cause progressive auditory neuropathy: a new gene of auditory synaptopathy.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29184165","citation_count":48,"is_preprint":false},{"pmid":"33868146","id":"PMC_33868146","title":"ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum.","date":"2021","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33868146","citation_count":47,"is_preprint":false},{"pmid":"27626066","id":"PMC_27626066","title":"A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.","date":"2016","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/27626066","citation_count":46,"is_preprint":false},{"pmid":"34161264","id":"PMC_34161264","title":"Early role for a Na+,K+-ATPase (ATP1A3) in brain development.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34161264","citation_count":44,"is_preprint":false},{"pmid":"25895915","id":"PMC_25895915","title":"CAOS-Episodic Cerebellar Ataxia, Areflexia, Optic Atrophy, and Sensorineural Hearing Loss: A Third Allelic Disorder of the ATP1A3 Gene.","date":"2015","source":"Journal of child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25895915","citation_count":41,"is_preprint":false},{"pmid":"24100174","id":"PMC_24100174","title":"Alternating hemiplegia of childhood in Denmark: clinical manifestations and ATP1A3 mutation status.","date":"2013","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/24100174","citation_count":39,"is_preprint":false},{"pmid":"31425744","id":"PMC_31425744","title":"Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition.","date":"2019","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/31425744","citation_count":39,"is_preprint":false},{"pmid":"30842972","id":"PMC_30842972","title":"Genotype-structure-phenotype relationships diverge in paralogs ATP1A1, ATP1A2, and ATP1A3.","date":"2019","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30842972","citation_count":38,"is_preprint":false},{"pmid":"24803225","id":"PMC_24803225","title":"Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings.","date":"2014","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/24803225","citation_count":38,"is_preprint":false},{"pmid":"31361359","id":"PMC_31361359","title":"Revising rapid-onset dystonia-parkinsonism: Broadening indications for ATP1A3 testing.","date":"2019","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/31361359","citation_count":36,"is_preprint":false},{"pmid":"29895895","id":"PMC_29895895","title":"Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia.","date":"2018","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29895895","citation_count":34,"is_preprint":false},{"pmid":"26990090","id":"PMC_26990090","title":"ATP1A3 Mutation in Adult Rapid-Onset Ataxia.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26990090","citation_count":34,"is_preprint":false},{"pmid":"27091223","id":"PMC_27091223","title":"The Genetic Homogeneity of CAPOS Syndrome: Four New Patients With the c.2452G>A (p.Glu818Lys) Mutation in the ATP1A3 Gene.","date":"2016","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27091223","citation_count":34,"is_preprint":false},{"pmid":"32280259","id":"PMC_32280259","title":"Alternating Hemiplegia of Childhood: Understanding the Genotype-Phenotype Relationship of ATP1A3 Variations.","date":"2020","source":"The application of clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32280259","citation_count":31,"is_preprint":false},{"pmid":"33144327","id":"PMC_33144327","title":"Misfolding, altered membrane distributions, and the unfolded protein response contribute to pathogenicity differences in Na,K-ATPase ATP1A3 mutations.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33144327","citation_count":28,"is_preprint":false},{"pmid":"29305691","id":"PMC_29305691","title":"The CAPOS mutation in ATP1A3 alters Na/K-ATPase function and results in auditory neuropathy which has implications for management.","date":"2018","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29305691","citation_count":28,"is_preprint":false},{"pmid":"24983657","id":"PMC_24983657","title":"Heterozygous mice deficient in Atp1a3 exhibit motor deficits by chronic restraint stress.","date":"2014","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/24983657","citation_count":26,"is_preprint":false},{"pmid":"24236096","id":"PMC_24236096","title":"Molecular cloning and characterization of porcine Na⁺/K⁺-ATPase isoforms α1, α2, α3 and the ATP1A3 promoter.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24236096","citation_count":25,"is_preprint":false},{"pmid":"31746080","id":"PMC_31746080","title":"Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31746080","citation_count":24,"is_preprint":false},{"pmid":"24713507","id":"PMC_24713507","title":"A novel ATP1A3 mutation with unique clinical presentation.","date":"2014","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24713507","citation_count":24,"is_preprint":false},{"pmid":"26453127","id":"PMC_26453127","title":"CAPOS syndrome and hemiplegic migraine in a novel pedigree with the specific ATP1A3 mutation.","date":"2015","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26453127","citation_count":24,"is_preprint":false},{"pmid":"24491413","id":"PMC_24491413","title":"Alternating hemiplegia of childhood with a de novo mutation in ATP1A3 and changes in SLC2A1 responsive to a ketogenic diet.","date":"2013","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24491413","citation_count":24,"is_preprint":false},{"pmid":"26417536","id":"PMC_26417536","title":"Intermediate Phenotypes of ATP1A3 Mutations: Phenotype-Genotype Correlations.","date":"2015","source":"Tremor and other hyperkinetic movements (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/26417536","citation_count":23,"is_preprint":false},{"pmid":"32802951","id":"PMC_32802951","title":"D-DEMØ, a distinct phenotype caused by ATP1A3 mutations.","date":"2020","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32802951","citation_count":23,"is_preprint":false},{"pmid":"29395663","id":"PMC_29395663","title":"ATP1A3-related epileptic encephalopathy responding to ketogenic diet.","date":"2018","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/29395663","citation_count":22,"is_preprint":false},{"pmid":"28465228","id":"PMC_28465228","title":"Knockout of sodium pump α3 subunit gene (Atp1a3-/-) results in perinatal seizure and defective respiratory rhythm generation.","date":"2017","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/28465228","citation_count":22,"is_preprint":false},{"pmid":"31616254","id":"PMC_31616254","title":"Recessive Inheritance of Congenital Hydrocephalus With Other Structural Brain Abnormalities Caused by Compound Heterozygous Mutations in ATP1A3.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31616254","citation_count":22,"is_preprint":false},{"pmid":"27634470","id":"PMC_27634470","title":"De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis.","date":"2016","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27634470","citation_count":22,"is_preprint":false},{"pmid":"29861155","id":"PMC_29861155","title":"Early-onset encephalopathy with paroxysmal movement disorders and epileptic seizures without hemiplegic attacks: About three children with novel ATP1A3 mutations.","date":"2018","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/29861155","citation_count":22,"is_preprint":false},{"pmid":"25439493","id":"PMC_25439493","title":"Identical ATP1A3 mutation causes alternating hemiplegia of childhood and rapid-onset dystonia parkinsonism phenotypes.","date":"2014","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25439493","citation_count":20,"is_preprint":false},{"pmid":"17595045","id":"PMC_17595045","title":"ATP1A3 mutation in the first asian case of rapid-onset dystonia-parkinsonism.","date":"2007","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/17595045","citation_count":20,"is_preprint":false},{"pmid":"32653672","id":"PMC_32653672","title":"Comparative analysis of alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism ATP1A3 mutations reveals functional deficits, which do not correlate with disease severity.","date":"2020","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32653672","citation_count":18,"is_preprint":false},{"pmid":"33577387","id":"PMC_33577387","title":"Adeno-Associated Virus-Mediated Gene Therapy in the Mashlool, Atp1a3, Mouse Model of Alternating Hemiplegia of Childhood.","date":"2021","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33577387","citation_count":16,"is_preprint":false},{"pmid":"27146299","id":"PMC_27146299","title":"Treatment with Oral ATP decreases alternating hemiplegia of childhood with de novo ATP1A3 Mutation.","date":"2016","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/27146299","citation_count":16,"is_preprint":false},{"pmid":"23681173","id":"PMC_23681173","title":"Functional studies and proteomics in platelets and fibroblasts reveal a lysosomal defect with increased cathepsin-dependent apoptosis in ATP1A3 defective alternating hemiplegia of childhood.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23681173","citation_count":15,"is_preprint":false},{"pmid":"31959558","id":"PMC_31959558","title":"ATP1A3-related epilepsy: Report of seven cases and literature-based analysis of treatment response.","date":"2020","source":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","url":"https://pubmed.ncbi.nlm.nih.gov/31959558","citation_count":14,"is_preprint":false},{"pmid":"30363590","id":"PMC_30363590","title":"Beyond Dystonia-Parkinsonism: Chorea and Ataxia with ATP1A3 Mutations.","date":"2016","source":"Movement disorders clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/30363590","citation_count":14,"is_preprint":false},{"pmid":"24291144","id":"PMC_24291144","title":"Asystole in alternating hemiplegia with de novo ATP1A3 mutation.","date":"2013","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24291144","citation_count":14,"is_preprint":false},{"pmid":"36866063","id":"PMC_36866063","title":"The role of ATP1A3 gene in epilepsy: We need to know more.","date":"2023","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36866063","citation_count":13,"is_preprint":false},{"pmid":"34342181","id":"PMC_34342181","title":"Variants of ATP1A3 in residue 756 cause a separate phenotype of relapsing encephalopathy with cerebellar ataxia (RECA)-Report of two cases and literature review.","date":"2021","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34342181","citation_count":13,"is_preprint":false},{"pmid":"29922587","id":"PMC_29922587","title":"De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome.","date":"2018","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/29922587","citation_count":13,"is_preprint":false},{"pmid":"34612482","id":"PMC_34612482","title":"Genetically altered animal models for ATP1A3-related disorders.","date":"2021","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/34612482","citation_count":12,"is_preprint":false},{"pmid":"29057568","id":"PMC_29057568","title":"Atp1a3-deficient heterozygous mice show lower rank in the hierarchy and altered social behavior.","date":"2017","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/29057568","citation_count":12,"is_preprint":false},{"pmid":"26003227","id":"PMC_26003227","title":"Common variants of ATP1A3 but not ATP1A2 are associated with Chinese genetic generalized epilepsies.","date":"2015","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26003227","citation_count":12,"is_preprint":false},{"pmid":"35968298","id":"PMC_35968298","title":"Molecular and clinical characteristics of ATP1A3-related diseases.","date":"2022","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35968298","citation_count":11,"is_preprint":false},{"pmid":"37043503","id":"PMC_37043503","title":"Cation leak through the ATP1A3 pump causes spasticity and intellectual disability.","date":"2023","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37043503","citation_count":11,"is_preprint":false},{"pmid":"29396171","id":"PMC_29396171","title":"ATP1A3 spectrum disorders: A video-documented history of 7 genetically confirmed early onset cases.","date":"2018","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/29396171","citation_count":11,"is_preprint":false},{"pmid":"29066118","id":"PMC_29066118","title":"A de novo p.Arg756Cys mutation in ATP1A3 causes a distinct phenotype with prolonged weakness and encephalopathy triggered by fever.","date":"2017","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/29066118","citation_count":11,"is_preprint":false},{"pmid":"27936181","id":"PMC_27936181","title":"In Vivo Modelling of ATP1A3 G316S-Induced Ataxia in C. elegans Using CRISPR/Cas9-Mediated Homologous Recombination Reveals Dominant Loss of Function Defects.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27936181","citation_count":11,"is_preprint":false},{"pmid":"32339621","id":"PMC_32339621","title":"Mutational and phenotypic expansion of ATP1A3-related disorders: Report of nine cases.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32339621","citation_count":10,"is_preprint":false},{"pmid":"32454213","id":"PMC_32454213","title":"Long-term follow-up and novel genotype-phenotype analysis of monozygotic twins with ATP1A3 mutation in Alternating Hemiplegia of Childhood-2.","date":"2020","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32454213","citation_count":10,"is_preprint":false},{"pmid":"40029639","id":"PMC_40029639","title":"ATP1A3 Variants, Variably Penetrant Short QT Intervals, and Lethal Ventricular Arrhythmias.","date":"2025","source":"JAMA pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/40029639","citation_count":9,"is_preprint":false},{"pmid":"32440726","id":"PMC_32440726","title":"ATP1A3 mutation as a candidate cause of autosomal dominant cone-rod dystrophy.","date":"2020","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32440726","citation_count":9,"is_preprint":false},{"pmid":"36462665","id":"PMC_36462665","title":"Temperature instability of a mutation at a multidomain junction in Na,K-ATPase isoform ATP1A3 (p.Arg756His) produces a fever-induced neurological syndrome.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36462665","citation_count":9,"is_preprint":false},{"pmid":"35978945","id":"PMC_35978945","title":"ATP1A3 mutation in rapid-onset dystonia parkinsonism: New data and genotype-phenotype correlation analysis.","date":"2022","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35978945","citation_count":8,"is_preprint":false},{"pmid":"30392841","id":"PMC_30392841","title":"A case of early onset life-threatening epilepsy associated with a novel ATP1A3 gene variant.","date":"2018","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/30392841","citation_count":8,"is_preprint":false},{"pmid":"38804677","id":"PMC_38804677","title":"ATP1A3 regulates protein synthesis for mitochondrial stability under heat stress.","date":"2024","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/38804677","citation_count":7,"is_preprint":false},{"pmid":"30011403","id":"PMC_30011403","title":"Early Life Epilepsy and Episodic Apnea Revealing an ATP1A3 Mutation: Report of a Pediatric Case and Literature Review.","date":"2018","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/30011403","citation_count":7,"is_preprint":false},{"pmid":"29625811","id":"PMC_29625811","title":"Further characterization of CAPOS/CAOS syndrome with the Glu818Lys mutation in the ATP1A3 gene: A case report.","date":"2018","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/29625811","citation_count":7,"is_preprint":false},{"pmid":"32043468","id":"PMC_32043468","title":"Epileptic encephalopathy with features of rapid-onset dystonia Parkinsonism and alternating hemiplegia of childhood: a novel combination phenotype associated with ATP1A3 mutation.","date":"2020","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/32043468","citation_count":7,"is_preprint":false},{"pmid":"29269014","id":"PMC_29269014","title":"Long-term follow up of an adult with alternating hemiplegia of childhood and a p.Gly755Ser mutation in the ATP1A3 gene.","date":"2018","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/29269014","citation_count":7,"is_preprint":false},{"pmid":"29801192","id":"PMC_29801192","title":"Variants in the ATP1A3 Gene Mutations within Severe Apnea Starting in Early Infancy: An Observational Study of Two Cases with a Possible Relation to Epileptic Activity.","date":"2018","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/29801192","citation_count":7,"is_preprint":false},{"pmid":"11353452","id":"PMC_11353452","title":"Absence of a significant linkage between Na(+),K(+)-ATPase subunit (ATP1A3 and ATP1B3) genotypes and bipolar affective disorder in the old-order Amish.","date":"2001","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11353452","citation_count":7,"is_preprint":false},{"pmid":"39797721","id":"PMC_39797721","title":"Progressive central cardiorespiratory rate downregulation and intensifying epilepsy lead to sudden unexpected death in epilepsy in mouse model of the most common human ATP1A3 mutation.","date":"2025","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/39797721","citation_count":6,"is_preprint":false},{"pmid":"38243045","id":"PMC_38243045","title":"Childhood-related neural genotype-phenotype in ATP1A3 mutations: comprehensive analysis.","date":"2024","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38243045","citation_count":6,"is_preprint":false},{"pmid":"33326973","id":"PMC_33326973","title":"The Expanding Phenotypic Spectrums Associated with ATP1A3 Mutation in a Family with Rapid-Onset Dystonia Parkinsonism.","date":"2020","source":"Neuro-degenerative diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33326973","citation_count":6,"is_preprint":false},{"pmid":"34692702","id":"PMC_34692702","title":"Auditory Neuropathy as the Initial Phenotype for Patients With ATP1A3 c.2452 G > A: Genotype-Phenotype Study and CI Management.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34692702","citation_count":6,"is_preprint":false},{"pmid":"25662428","id":"PMC_25662428","title":"ATP1A3 mutation in a Chinese girl with alternating hemiplegia of childhood--Potential target of treatment?","date":"2015","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/25662428","citation_count":6,"is_preprint":false},{"pmid":"25359261","id":"PMC_25359261","title":"Genome sequencing identifies a novel mutation in ATP1A3 in a family with dystonia in females only.","date":"2014","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25359261","citation_count":6,"is_preprint":false},{"pmid":"33082768","id":"PMC_33082768","title":"Effect of Flunarizine on Alternating Hemiplegia of Childhood in a Patient with the p.E815K Mutation in ATP1A3: A Case Report.","date":"2020","source":"Case reports in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33082768","citation_count":6,"is_preprint":false},{"pmid":"36484864","id":"PMC_36484864","title":"ATP1A3-related phenotypes in Chinese children: AHC, CAPOS, and RECA.","date":"2022","source":"European journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/36484864","citation_count":5,"is_preprint":false},{"pmid":"15254951","id":"PMC_15254951","title":"Refined linkage to the RDP/DYT12 locus on 19q13.2 and evaluation of GRIK5 as a candidate gene.","date":"2004","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/15254951","citation_count":5,"is_preprint":false},{"pmid":"33451880","id":"PMC_33451880","title":"Rapid-onset dystonia-parkinsonism with ATP1A3 mutation and left lower limb paroxysmal dystonia.","date":"2021","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/33451880","citation_count":5,"is_preprint":false},{"pmid":"37293976","id":"PMC_37293976","title":"Epilepsy with eyelid myoclonia in the setting of de novo pathogenic variant in ATP1A3.","date":"2023","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/37293976","citation_count":5,"is_preprint":false},{"pmid":"39533828","id":"PMC_39533828","title":"ATP1A3 dysfunction causes motor hyperexcitability and afterhyperpolarization loss in a dystonia model.","date":"2025","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/39533828","citation_count":4,"is_preprint":false},{"pmid":"35382416","id":"PMC_35382416","title":"Chinese patients with p.Arg756 mutations of ATP1A3: Clinical manifestations, treatment, and follow-up.","date":"2022","source":"Pediatric investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35382416","citation_count":4,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51800,"output_tokens":5006,"usd":0.115245,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13543,"output_tokens":5176,"usd":0.098558,"stage2_stop_reason":"end_turn"},"total_usd":0.213803,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Six missense mutations in ATP1A3 (encoding the Na+/K+-ATPase α3 subunit) were identified in rapid-onset dystonia-parkinsonism (RDP/DYT12) families; functional studies and structural analysis indicated these mutations impair enzyme activity or stability of the Na+/K+ pump.\",\n      \"method\": \"Missense mutation identification, functional studies, structural analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — functional enzymatic assays combined with structural analysis, replicated across multiple families and subsequently confirmed by many independent labs\",\n      \"pmids\": [\"15260953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"De novo nonsynonymous ATP1A3 mutations in alternating hemiplegia of childhood (AHC) cause consistent reductions in ATPase activity without affecting protein expression level, distinguishing them mechanistically from RDP mutations which impair enzyme activity or stability.\",\n      \"method\": \"Exome sequencing, ATPase activity assays in patient-derived cells, protein expression analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct in vitro enzymatic assay with multiple mutations, replicated across large cohort, multiple orthogonal methods\",\n      \"pmids\": [\"22842232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"An in-frame C-terminal insertion mutation in ATP1A3 causes RDP by drastically reducing Na+ affinity at the third Na+ binding site, without defects in protein biogenesis or plasma membrane targeting; structural modelling demonstrated the C-terminus interacts with the third Na+ binding site to stabilize E1/E2 conformations.\",\n      \"method\": \"Expression studies, functional Na+ affinity analysis, structural modelling, ouabain challenge survival assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic characterization with mutagenesis and structural modelling, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"19351654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Novel ATP1A3 mutations (p.Gly358Val and p.Ile363Asn) localizing to the P domain result in significant reduction of Na,K-ATPase activity in vitro; ATP1A3 immunofluorescence in human brain tissue is prominently associated with interneurons in the cortex.\",\n      \"method\": \"In vitro ATPase activity assay, immunofluorescence in human brain tissue\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Weak — direct in vitro enzymatic assay, single lab study\",\n      \"pmids\": [\"25656163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In Atp1a3 heterozygous knockout mice, the α3 subunit is concentrated presynaptically at Purkinje cell soma (co-localizing with VGAT), and loss of one Atp1a3 allele enhances inhibitory neurotransmission at molecular-layer interneuron–Purkinje cell synapses via a presynaptic mechanism, leading to increased dystonia symptoms after cerebellar kainate injection.\",\n      \"method\": \"Immunohistochemistry, electrophysiology (patch-clamp of cerebellar slices), Atp1a3 heterozygous knockout mouse, behavioral dystonia assay\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal localization and electrophysiology in KO mouse with defined cellular phenotype, multiple orthogonal methods in single study\",\n      \"pmids\": [\"23652595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ATP1A3 mutations causing severe phenotypes (microcephaly, brain atrophy) produce protein misfolding during biosynthesis, resulting in impaired trafficking of the α3β complex from ER through Golgi to plasma membrane; additionally, exogenous mutant α3 competes with endogenous α1 such that their total is constant, predicting variable ratios of normal to mutant protein in patients.\",\n      \"method\": \"Tetracycline-inducible isogenic HEK-293 cell lines, subcellular fractionation, immunofluorescence for Golgi/ER markers, Western blotting, cell survival assays\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal cell-biological methods in isogenic lines, single lab\",\n      \"pmids\": [\"31425744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Severe ATP1A3 mutations (e.g., L924P) cause greater ER retention of nascent α3, more ER-associated degradation (ERAD), larger perturbation of Na,K-ATPase subunit subcellular distribution, greater eIF2α inactivation (unfolded protein response), altered distribution of endogenous α1 (dominant-negative-like effect), and pro-apoptotic sensitization via reduced BAD phosphorylation; the pharmacological corrector 4-phenylbutyrate reduces L924P ER retention and restores morphology.\",\n      \"method\": \"Isogenic inducible cell lines, subcellular fractionation, Western blotting, UPR pathway analysis, pharmacological rescue with 4-PBA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal mechanistic assays in isogenic cell system, pharmacological validation, single lab\",\n      \"pmids\": [\"33144327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The CAPOS mutation p.Glu818Lys in ATP1A3 specifically affects sodium binding to and release from the third (sodium-specific) ion-binding site of the pump, as demonstrated by in vitro electrophysiological studies; molecular dynamics simulations confirm structural perturbation of the C-terminal region.\",\n      \"method\": \"Heterologous expression, in vitro electrophysiology (pump current measurements), molecular dynamics simulation\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct electrophysiological measurement of ion binding kinetics plus molecular dynamics, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"29305691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ATP1A3 is expressed in fetal cortical subplate excitatory neurons and postnatal inhibitory neurons (including parvalbumin interneurons); the Na+/K+-ATPase pump complex forms cell-type-specific α-β isoform combinations: α3-β1 in excitatory neurons and α3-β2 in inhibitory neurons, as shown by single-cell RNA sequencing of ~125,000 fetal cortical cells.\",\n      \"method\": \"mRNA in situ hybridization, single-cell RNA sequencing (Drop-seq) of ~125,000 fetal cortical cells and ~52,000 infant cortical nuclei\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — large-scale single-cell transcriptomics with in situ validation, cell-type specific isoform pairing established, single lab but large dataset with orthogonal validation\",\n      \"pmids\": [\"34161264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The p.Arg756His mutation in ATP1A3 reduces protein turnover rate and Na+ affinity and increases K+ affinity; at 39°C (fever), α3 protein level drops due to internalization from the cell surface and lysosomal/endosomal routing, without loss of β subunit; recovery requires new protein synthesis; heating in vitro causes activity loss 20-30-fold faster than wildtype, demonstrating temperature-dependent structural destabilization. Arg756 normally forms hydrogen bonds anchoring four linearly distant structural regions.\",\n      \"method\": \"Isogenic mammalian cell lines, transport activity assays at 37°C and 39°C, immunofluorescence for subcellular localization (LAMP1 marker), cycloheximide chase, in vitro heating activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal assays (activity, localization, thermal stability, biosynthesis) in controlled isogenic cells, single lab\",\n      \"pmids\": [\"36462665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Twelve RDP and AHC-specific ATP1A3 mutations expressed in HEK cells and Xenopus oocytes all showed functional impairment (lower cell survival and reduced pump current), but no difference in extent of impairment or expression level was found between RDP and AHC phenotypes, indicating that pump dysfunction magnitude alone does not determine disease severity.\",\n      \"method\": \"Transfected HEK cells, Xenopus oocyte electrophysiology (pump current measurement), cell survival assay\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct electrophysiological and enzymatic assays across 12 mutations, multiple expression systems, single lab\",\n      \"pmids\": [\"32653672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Complete knockout of Atp1a3 (Atp1a3-/-) in mice results in perinatal seizures, failure of effective breathing, and death; knockout brains show elevated c-Fos expression in multiple regions (with unique cerebellar distribution) and higher dopamine and noradrenaline contents; brainstem preparations show abnormal respiratory rhythms, demonstrating α3 is required for normal respiratory rhythm generation and monoamine homeostasis.\",\n      \"method\": \"Atp1a3 knockout mouse, c-Fos immunohistochemistry, monoamine HPLC measurement, brainstem preparation electrophysiology, behavioral observation\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with multiple defined cellular/physiological phenotypes using orthogonal methods, single lab\",\n      \"pmids\": [\"28465228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The recurrent ATP1A3 p.Pro775Leu variant uniquely causes leakage of sodium ions and protons into the cell (cation leak), associated with impaired sodium binding/occlusion kinetics favouring states with fewer bound ions, producing a mild spasticity/intellectual disability phenotype distinct from other ATP1A3-related syndromes.\",\n      \"method\": \"Electrophysiological characterization of ion transport kinetics in heterologous expression system, biophysical analysis of sodium occlusion\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct electrophysiological assay revealing novel cation leak mechanism, single lab, novel mechanism with functional validation\",\n      \"pmids\": [\"37043503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The intracellular loop (ICL) of ATP1A3 interacts with RNA-binding proteins Eif4g (Eif4g1), Pabpc1, and Fmrp (Fmr1) in mouse Neuro2a cells; siRNA depletion of Atp1a3 or expression of p.R756C ATP1A3-ICL causes excessive phosphorylation of ribosomal protein S6 and increased susceptibility to heat stress; patient iPSC-derived neurons with p.R756C showed reduced calcium influx in response to ATP stimulation.\",\n      \"method\": \"Co-immunoprecipitation/pulldown for RNA-binding protein interaction, siRNA knockdown, ectopic expression of ICL domain, S6 phosphorylation Western blotting, heat stress assay, iPSC-derived neurons, calcium imaging\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — protein-protein interaction and downstream signalling with multiple orthogonal methods, single lab, novel ICL binding partner finding\",\n      \"pmids\": [\"38804677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In Atp1a3 mutant mice (D801N), motor neurons exhibit loss of Na+/K+-ATPase-mediated afterhyperpolarization and impaired intracellular sodium extrusion, resulting in reduced responsiveness of the spinal motor network to activity-dependent sodium rises and a hyperexcitable motor phenotype compatible with dystonia.\",\n      \"method\": \"Atp1a3 mutant mouse (D801N knock-in), intracellular electrophysiology of motor neurons, sodium imaging, spinal motor network recordings\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct electrophysiological measurement of afterhyperpolarization and sodium homeostasis in knock-in mouse, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"39533828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AAV9-mediated delivery of human ATP1A3 under the Synapsin promoter into Atp1a3 D801N mutant mice increased ouabain-sensitive ATPase activity in brain regions, reduced inducible hemiplegia spells, improved balance beam performance, and prolonged survival, demonstrating that supplementing wild-type α3 pump activity can rescue disease phenotypes.\",\n      \"method\": \"AAV9 gene delivery (intracerebroventricular and intracisterna magna injection), ATPase activity assay, behavioral testing, survival analysis in knock-in mice\",\n      \"journal\": \"Human gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo functional rescue with enzymatic validation and behavioral readouts, single lab\",\n      \"pmids\": [\"33577387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Platelets and fibroblasts from AHC patients with ATP1A3 mutations (D801N or E815K) show lysosomal granule structural and functional abnormalities (CD63+ granule defects) and significantly increased activated cathepsin B levels, leading to enhanced intrinsic apoptosis.\",\n      \"method\": \"Platelet and fibroblast morphology, flow cytometry (CD63), proteomic analysis (TMT), cathepsin B activity assay, apoptosis assay\",\n      \"journal\": \"Journal of proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — multiple orthogonal methods in patient-derived cells across two cell types, single lab\",\n      \"pmids\": [\"23681173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In iPSC-derived cardiomyocytes from D801N ATP1A3 patients, the D801N variant shortens action potential duration, increases mean diastolic potential, and causes delayed afterdepolarizations compared to controls, consistent with short QT interval and arrhythmic susceptibility observed clinically; the D801N variant and other short-QT-associated variants localize to the potassium-binding domain of ATP1A3.\",\n      \"method\": \"iPSC-derived cardiomyocytes, action potential recordings, cryo-EM structure mapping, clinical QTc measurements\",\n      \"journal\": \"JAMA pediatrics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct electrophysiological validation in patient-derived iPSC-cardiomyocytes combined with structural domain mapping and clinical data, multiple orthogonal methods\",\n      \"pmids\": [\"40029639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The ATP1A3 G316S mutation modelled in C. elegans eat-6 (orthologue of ATP1A3) via CRISPR/Cas9 knock-in causes dominant loss-of-function at the neuromuscular junction: decreased pharyngeal pumping rate and hypersensitivity to aldicarb (acetylcholinesterase inhibitor), demonstrating impaired neuromuscular function.\",\n      \"method\": \"CRISPR/Cas9 knock-in in C. elegans, pharyngeal pumping assay, aldicarb sensitivity assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo CRISPR knock-in model with two behavioural assays establishing dominant loss-of-function mechanism at NMJ, single lab\",\n      \"pmids\": [\"27936181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The porcine ATP1A3 promoter drives expression specifically in embryonic brain and spinal cord neurons in transgenic zebrafish, confirming neuron-specific transcriptional activity; ATP1A3 mRNA expression is confined to neuronal tissue with expression detectable in embryonic porcine brain from 60 days of gestation.\",\n      \"method\": \"Transgenic zebrafish reporter assay, qRT-PCR tissue expression profiling, protein immunoblotting\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic promoter assay with qPCR and protein validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"24236096\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP1A3 encodes the neuron-specific α3 catalytic subunit of the Na+/K+-ATPase pump, which maintains electrochemical gradients essential for neuronal excitability; pathogenic mutations impair pump ATPase activity, reduce Na+ affinity, cause protein misfolding/ER retention with activation of the unfolded protein response, disrupt α3β isoform trafficking to the plasma membrane, abolish the Na+/K+-ATPase-mediated afterhyperpolarization in motor neurons (resulting in hyperexcitability and dystonia), and in some cases cause cation leak or temperature-dependent structural destabilization; the α3 subunit also interacts with RNA-binding proteins via its intracellular loop to regulate protein synthesis under stress, forms cell-type-specific heteromeric complexes (α3-β1 in excitatory, α3-β2 in inhibitory neurons), and its dysfunction in cardiac cells impairs ventricular repolarization causing arrhythmic susceptibility.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ATP1A3 encodes the neuron-specific \\u03b13 catalytic subunit of the Na+/K+-ATPase, the active ion pump whose ouabain-sensitive ATPase activity maintains transmembrane Na+/K+ gradients required for neuronal excitability, and its expression is restricted to neuronal tissue of the brain and spinal cord [#11, #19]. The pump assembles into cell-type-specific heteromeric complexes, pairing \\u03b13 with \\u03b21 in excitatory neurons and with \\u03b22 in inhibitory interneurons [#8]. Heterozygous and missense loss-of-function alleles cause a spectrum of dominant neurological disease \\u2014 rapid-onset dystonia-parkinsonism (RDP/DYT12), alternating hemiplegia of childhood (AHC), and CAPOS \\u2014 through several distinct biophysical lesions: reduction of catalytic ATPase activity [#0, #1, #3, #10], loss of Na+ affinity at the third (sodium-specific) ion-binding site via C-terminal perturbation [#2, #7], pathological cation leak of Na+ and protons [#12], and temperature-dependent structural destabilization that triggers fever-induced surface loss of \\u03b13 [#9]. The most severe alleles act through a biogenesis defect: misfolded nascent \\u03b13 is retained in the ER, undergoes ERAD, activates the unfolded protein response via eIF2\\u03b1, exerts a dominant-negative effect on endogenous \\u03b11 distribution, and sensitizes cells to apoptosis, a phenotype reversible by the chemical chaperone 4-phenylbutyrate [#5, #6]. At the circuit level \\u03b13 dysfunction abolishes Na+/K+-ATPase-mediated afterhyperpolarization in motor neurons and dysregulates inhibitory transmission, producing hyperexcitability and dystonia [#4, #14], while complete loss is incompatible with normal respiratory rhythm and monoamine homeostasis [#11]. Beyond ion transport, the \\u03b13 intracellular loop binds the RNA-binding proteins Eif4g1, Pabpc1, and Fmrp to restrain ribosomal S6 phosphorylation and protein synthesis under stress [#13]. \\u03b13 dysfunction also impairs cardiac repolarization, causing short-QT and arrhythmic susceptibility [#17]. Restoring wild-type \\u03b13 pump activity by AAV9 gene delivery rescues disease phenotypes in mutant mice, establishing reduced pump function as the proximate cause [#15].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established ATP1A3 as a disease gene by linking missense mutations to rapid-onset dystonia-parkinsonism and tying them to impaired pump enzyme activity/stability.\",\n      \"evidence\": \"Mutation identification in RDP families with functional and structural analysis\",\n      \"pmids\": [\"15260953\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which biophysical step of the pump cycle each mutation impairs\", \"No in vivo circuit-level mechanism\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Resolved one biophysical lesion: a C-terminal insertion reduces Na+ affinity at the third Na+ site without affecting biogenesis or membrane targeting, implicating the C-terminus in stabilizing E1/E2 conformations.\",\n      \"evidence\": \"Heterologous expression, Na+ affinity assays, structural modelling, ouabain survival assay\",\n      \"pmids\": [\"19351654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability to other RDP mutations unaddressed\", \"No direct structure of mutant pump\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Distinguished AHC from RDP mechanistically by showing AHC de novo mutations reduce ATPase activity without altering protein expression level.\",\n      \"evidence\": \"Exome sequencing plus ATPase activity and expression assays in patient cells\",\n      \"pmids\": [\"22842232\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not explain phenotypic divergence given shared activity loss\", \"No structural mapping of severity\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined the cellular and synaptic consequences of \\u03b13 loss in vivo, localizing the subunit presynaptically and linking haploinsufficiency to enhanced inhibition and dystonia.\",\n      \"evidence\": \"Atp1a3 heterozygous KO mouse, immunohistochemistry, cerebellar slice electrophysiology, behavioral dystonia assay\",\n      \"pmids\": [\"23652595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Presynaptic mechanism for enhanced inhibition not fully resolved\", \"Cerebellar focus leaves other circuits open\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended pathology beyond ion transport, showing patient cells carry lysosomal granule defects and elevated cathepsin B driving apoptosis.\",\n      \"evidence\": \"Patient platelet/fibroblast morphology, CD63 flow cytometry, proteomics, cathepsin B and apoptosis assays\",\n      \"pmids\": [\"23681173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal link from pump dysfunction to lysosomal phenotype not established\", \"Two cell types, single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated \\u03b13 is essential for life by showing complete knockout causes perinatal lethality, respiratory rhythm failure, and monoamine dysregulation.\",\n      \"evidence\": \"Atp1a3 knockout mouse, c-Fos IHC, monoamine HPLC, brainstem electrophysiology\",\n      \"pmids\": [\"28465228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-autonomous vs network origin of respiratory failure unresolved\", \"Monoamine changes mechanism unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Provided direct biophysical evidence that the CAPOS mutation specifically disrupts Na+ binding/release at the third ion site through C-terminal perturbation.\",\n      \"evidence\": \"Heterologous expression, pump current electrophysiology, molecular dynamics simulation\",\n      \"pmids\": [\"29305691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Link from biophysical defect to CAPOS-specific clinical features not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified protein misfolding and trafficking failure as the lesion behind the most severe phenotypes, with mutant \\u03b13 competing with \\u03b11 to set a fixed total subunit pool.\",\n      \"evidence\": \"Isogenic inducible HEK-293 lines, fractionation, ER/Golgi immunofluorescence, Western blot\",\n      \"pmids\": [\"31425744\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of competition model untested\", \"Single cell system\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Detailed the biogenesis defect mechanistically (ER retention, ERAD, UPR via eIF2\\u03b1, dominant-negative effect on \\u03b11, apoptotic sensitization) and showed pharmacological correction by 4-PBA.\",\n      \"evidence\": \"Isogenic inducible cell lines, fractionation, UPR pathway analysis, 4-PBA rescue\",\n      \"pmids\": [\"33144327\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether 4-PBA rescues function in neurons untested\", \"Single lab cell model\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Tested whether magnitude of pump dysfunction explains phenotype severity and found it does not, decoupling activity loss from RDP-vs-AHC outcome.\",\n      \"evidence\": \"12 mutations in HEK cells and Xenopus oocytes, pump current and survival assays\",\n      \"pmids\": [\"32653672\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What does determine severity remains unidentified\", \"In vitro systems lack neuronal context\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapped cell-type-specific subunit pairing, showing \\u03b13-\\u03b21 in excitatory and \\u03b13-\\u03b22 in inhibitory neurons and developmental shifts in expression.\",\n      \"evidence\": \"Single-cell RNA-seq of ~125,000 fetal cortical cells with in situ hybridization validation\",\n      \"pmids\": [\"34161264\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of isoform pairing untested\", \"Transcript-level pairing not validated at protein-complex level\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established that supplementing wild-type \\u03b13 pump activity is therapeutic, providing causal proof that pump deficiency drives disease.\",\n      \"evidence\": \"AAV9-Synapsin ATP1A3 delivery in D801N mice, ATPase assay, behavior, survival\",\n      \"pmids\": [\"33577387\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Durability and translatability untested\", \"Did not address dominant-negative alleles\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Explained fever-triggered episodes by showing a mutation confers temperature-dependent destabilization with surface internalization and lysosomal routing at 39\\u00b0C.\",\n      \"evidence\": \"Isogenic cells, transport assays at 37/39\\u00b0C, LAMP1 immunofluorescence, cycloheximide chase, in vitro thermal stability\",\n      \"pmids\": [\"36462665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo confirmation in neurons during fever lacking\", \"Trafficking machinery mediating internalization unidentified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified cation leak as a distinct disease mechanism, with a variant allowing Na+ and proton leak associated with a milder phenotype.\",\n      \"evidence\": \"Electrophysiological ion transport kinetics and occlusion analysis in heterologous expression\",\n      \"pmids\": [\"37043503\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequences of leak in neurons untested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed a non-pumping moonlighting function: the \\u03b13 intracellular loop binds RNA-binding proteins to regulate translation and stress responses.\",\n      \"evidence\": \"Co-IP for Eif4g1/Pabpc1/Fmr1, siRNA, ICL ectopic expression, S6 phosphorylation, heat stress, iPSC neuron calcium imaging\",\n      \"pmids\": [\"38804677\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect binding not resolved by single Co-IP-based study\", \"Physiological relevance of translation control in vivo untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected \\u03b13 dysfunction to a circuit-level dystonia mechanism: loss of pump-mediated afterhyperpolarization and impaired Na+ extrusion produce motor neuron hyperexcitability.\",\n      \"evidence\": \"D801N knock-in mouse, motor neuron intracellular electrophysiology, sodium imaging, spinal network recordings\",\n      \"pmids\": [\"39533828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Translation to human motor circuits untested\", \"Therapeutic correction at this level not shown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended \\u03b13 function to cardiac repolarization, showing the D801N variant shortens action potentials and causes afterdepolarizations underlying short-QT arrhythmia risk.\",\n      \"evidence\": \"Patient iPSC-derived cardiomyocytes, action potential recordings, cryo-EM domain mapping, clinical QTc\",\n      \"pmids\": [\"40029639\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking K+-binding-domain variants to repolarization not fully resolved\", \"In vivo arrhythmia modeling lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"What determines the divergent clinical phenotypes (RDP, AHC, CAPOS, spasticity, short-QT) given that activity-loss magnitude alone does not predict severity remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying genotype-phenotype mechanistic model\", \"Relative contribution of pump-loss, cation leak, misfolding, and moonlighting functions to specific syndromes unquantified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 1, 10, 15]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [2, 7, 12]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [4, 14]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 9]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [9, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [2, 7, 12]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4, 14, 11]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [6, 9]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\"Na+/K+-ATPase (\\u03b13-\\u03b21 / \\u03b13-\\u03b22 heteromer)\"],\n    \"partners\": [\"ATP1B1\", \"ATP1B2\", \"ATP1A1\", \"EIF4G1\", \"PABPC1\", \"FMR1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}